| PUBCHEM ID |
71661251
|
| UNII |
632L571YDK
|
| Preferred Term |
ELBASVIR
|
| CAS |
1370468-36-2
|
| INCHIKEY |
BVAZQCUMNICBAQ-PZHYSIFUSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CC(C)[C@@H](C(N(CCC1)[C@@H]1c1ncc(-c(cc2)cc3c2n([C@H](c2ccccc2)Oc2c-4ccc(-c5cnc([C@H](CCC6)N6C([C@H](C(C)C)NC(OC)=O)=O)[nH]5)c2)c4c3)[nH]1)=O)NC(OC)=O
|
| Total Surface Area |
660,4
|
| Relative PSA |
0,25586
|
| TPSA |
188,8
|
| cLogS |
-8,329
|
| MW |
882,032
|
| cLogP |
7,0411
|
| H-Acceptors |
16
|
| H-Donors |
4
|
| Ro5 violations |
3
|
| Druglikeness |
-7,1562
|
| DrugScore |
5,83043601228222E-02
|
| Mutagenic |
low
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,7929
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Inhibitor
|
| P-glycoprotein Inhibitor II |
Inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Inhibitor
|
| CYP450 3A4 Inhibitor |
Inhibitor
|
| CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,2082
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,5067
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,6407
|
| Carcinogenicity (Three-class) |
Non-required
|
